Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Veerle Melotte
Affiliation
Maastricht University Medical Center.
ORCID
Career Start Year
2007
Papers
52
H Index
25
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37426341
Unbiased characterization of the larval zebrafish enteric nervous system at a single cell transcriptomic level.
iScience
2023
38009742
Gut Isolation from Zebrafish Larvae for Single-cell RNA Sequencing.
J Vis Exp
2023
37537688
Promoter hypermethylation of neural-related genes is compatible with stemness in solid cancers.
Epigenetics Chromatin
2023
37010851
An optimization and refinement of the whole-gut transit assay in mice.
Neurogastroenterol Motil
2023
37029200
Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial.
Br J Cancer
2023
34236124
The gut brain in a dish: Murine primary enteric nervous system cell cultures.
Neurogastroenterol Motil
2022
35584320
Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste?
Clin Transl Gastroenterol
2022
35477541
Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers.
Clin Epigenetics
2022
35874825
<i>TFAP2B</i> Haploinsufficiency Impacts Gastrointestinal Function and Leads to Pediatric Intestinal Pseudo-obstruction.
Front Cell Dev Biol
2022
36056202
Nerves in gastrointestinal cancer: from mechanism to modulations.
Nat Rev Gastroenterol Hepatol
2022
34904929
ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer.
Autophagy
2022
31402218
Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review.
Eur Urol Oncol
2021
33770200
The enteric nervous system in gastrointestinal disease etiology.
Cell Mol Life Sci
2021
33890711
Loss of enteric neuronal Ndrg4 promotes colorectal cancer via increased release of Nid1 and Fbln2.
EMBO Rep
2021
33858496
Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC.
Clin Epigenetics
2021
34385566
WHO grade I meningiomas that show regrowth after gamma knife radiosurgery often show 1p36 loss.
Sci Rep
2021
34216725
Intestinal multicellular organoids to study colorectal cancer.
Biochim Biophys Acta Rev Cancer
2021
33466373
The Emerging Role of Nerves and Glia in Colorectal Cancer.
Cancers (Basel)
2021
32256485
Chronic Intra-Uterine <i>Ureaplasma parvum</i> Infection Induces Injury of the Enteric Nervous System in Ovine Fetuses.
Front Immunol
2020
32883198
Chorioamnionitis induces enteric nervous system injury: effects of timing and inflammation in the ovine fetus.
Mol Med
2020
32591823
Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial.
Dis Esophagus
2020
32351513
Corrigendum: Chronic Intra-Uterine <i>Ureaplasma parvum</i> Infection Induces Injury of the Enteric Nervous System in Ovine Fetuses.
Front Immunol
2020
31172308
Correction to: KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study.
Gastric Cancer
2019
31764091
Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
Am J Gastroenterol
2019
31485792
Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system.
Neurogenetics
2019
31334235
Building a Professional Identity and an Academic Career Track in Translational Medicine.
Front Med (Lausanne)
2019
31111275
KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study.
Gastric Cancer
2019
28733262
Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
Clin Gastroenterol Hepatol
2018
29867106
Epigenetics in renal cell cancer: mechanisms and clinical applications.
Nat Rev Urol
2018
30033230
A combined literature and in silico analysis enlightens the role of the NDRG family in the gut.
Biochim Biophys Acta Gen Subj
2018
29550565
Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.
Eur J Cancer
2018
29666440
Analysis of DNA methylation in cancer: location revisited.
Nat Rev Clin Oncol
2018
29713045
Author Correction: Analysis of DNA methylation in cancer: location revisited.
Nat Rev Clin Oncol
2018
29564023
Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.
Clin Epigenetics
2018
27756787
A Four-Gene Promoter Methylation Marker Panel Consisting of <i>GREM1, NEURL, LAD1,</i> and <i>NEFH</i> Predicts Survival of Clear Cell Renal Cell Cancer Patients.
Clin Cancer Res
2017
28803494
Prognostic DNA methylation markers for renal cell carcinoma: a systematic review.
Epigenomics
2017
28847715
The role of enteric neurons in the development and progression of colorectal cancer.
Biochim Biophys Acta Rev Cancer
2017
28524415
NDRG4, an early detection marker for colorectal cancer, is specifically expressed in enteric neurons.
Neurogastroenterol Motil
2017
26953528
The emerging role of GATA transcription factors in development and disease.
Expert Rev Mol Med
2016
27118999
Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.
Clin Epigenetics
2016
25538088
Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood.
Cancer Prev Res (Phila)
2015
24375389
Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine.
Cancer Metastasis Rev
2014
24928946
CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
Clin Cancer Res
2014
24861629
Epigenetics in radiotherapy: where are we heading?
Radiother Oncol
2014
24560444
Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.
Mol Oncol
2014
23801749
The CpG island methylator phenotype: what's in a name?
Cancer Res
2013
22135045
DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
Cancer Prev Res (Phila)
2012
22449189
Promoter CpG island methylation markers in colorectal cancer: the road ahead.
Epigenomics
2012
20667976
The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications.
FASEB J
2010
19509152
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
Clin Cancer Res
2009
1 - 50 of 52
Column Actions
Search
Recommended Authors
Kathleen M Schieffer
Nationwide Children's Hospital
Career Start Year
2014
Number of shared co-authors
0
Daniela Hirsch
Institute of Pathology, University Medical Center Mannheim, University of Heidelberg
Career Start Year
2012
Number of shared co-authors
0
Huihui Fan
Center for Precision Health, The University of Texas Health Science Center at Houston
Career Start Year
2011
Number of shared co-authors
0
Asha A Nair
Mayo Clinic
Career Start Year
2010
Number of shared co-authors
0
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year
2008
Number of shared co-authors
4
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year
2007
Number of shared co-authors
0
Hui Zhao
College of Life Sciences, University of Chinese Academy of Sciences
Career Start Year
2007
Number of shared co-authors
0
Louis Vermeulen
Oncode Institute
Career Start Year
2006
Number of shared co-authors
4
Katia Nones
QIMR Berghofer Medical Research Institute
Career Start Year
2006
Number of shared co-authors
0
Eduardo Vilar
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
0
Kurt W Fisher
University of Nebraska Medical Center
Career Start Year
2004
Number of shared co-authors
0
Per-Henrik Edqvist
Uppsala University
Career Start Year
2004
Number of shared co-authors
0
Houtan Noushmehr
Henry Ford Hospital
Career Start Year
2003
Number of shared co-authors
2
Michael Slifker
Fox Chase Cancer Center
Career Start Year
2002
Number of shared co-authors
0
Susan L Woods
Adelaide Medical School, University of Adelaide
Career Start Year
2002
Number of shared co-authors
0
Alex Boussioutas
Royal Melbourne Hospital, University of Melbourne
Career Start Year
2001
Number of shared co-authors
0
Daniel L Worthley
South Australian Health and Medical Research Institute
Career Start Year
2001
Number of shared co-authors
0
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year
2000
Number of shared co-authors
1
Tobias Sj??blom
Uppsala University
Career Start Year
1999
Number of shared co-authors
0
Gregory S Yochum
The Pennsylvania State University College of Medicine
Career Start Year
1998
Number of shared co-authors
0
William M Grady
. Fred Hutchinson Cancer Center
Career Start Year
1997
Number of shared co-authors
3
John M Mariadason
Olivia Newton-John Cancer Research Institute
Career Start Year
1996
Number of shared co-authors
2
Phillip Buckhaults
University of South Carolina
Career Start Year
1993
Number of shared co-authors
0
Nathan Bahary
University of Pittsburgh
Career Start Year
1989
Number of shared co-authors
1
Robyn L Ward
University of Sydney
Career Start Year
1989
Number of shared co-authors
0
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year
1988
Number of shared co-authors
0
Timothy C Wang
Division of Gastroenterology and Irvine Cancer Research Center, Columbia University
Career Start Year
1988
Number of shared co-authors
0
Melissa H Wong
Oregon Health & Science University
Career Start Year
1988
Number of shared co-authors
0
Bharati Bapat
Mt Sinai Hospital
Career Start Year
1988
Number of shared co-authors
1
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Career Start Year
1983
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Manon van Engeland
Maastricht University Medical Center
Co-authored papers
28
Kim M Smits
Maastricht University Medical Center+
Co-authored papers
20
Wim Van Criekinge
Ghent University
Co-authored papers
11
Gerrit A Meijer
The Netherlands Cancer Institute
Co-authored papers
10
Leander Van Neste
Maastricht University Medical Center
Co-authored papers
5
Hanneke E C Niessen
Maastricht University Medical Center
Co-authored papers
4
Cary Oberije
Maastricht University Medical Centre
Co-authored papers
2
Stephen B Baylin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Co-authored papers
2
Kornel E Schuebel
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health
Co-authored papers
2
Eric J T Belt
Albert Schweitzer Hospital
Co-authored papers
1
Marc Vooijs
Maastricht University Medical Centre+
Co-authored papers
1
Pim J French
Erasmus MC Cancer Institute
Co-authored papers
1
Johan Bussink
Radboud University, Nijmegen Medical Centre
Co-authored papers
1
David W Threadgill
College Station
Co-authored papers
1
Esther G C Troost
German Cancer Research Center (DKFZ)
Co-authored papers
1
Connie R Jimenez
Co-authored papers
1
Maud H W Starmans
Ontario Institute for Cancer Research
Co-authored papers
1
Marike W van Gisbergen
Maastricht University
Co-authored papers
1
Paul C Boutros
University of California los angeles
Co-authored papers
1
Philippe Lambin
Maastricht University
Co-authored papers
1
Jeroen A A Demmers
Erasmus Medical Center
Co-authored papers
1
Remond J A Fijneman
The Netherlands Cancer Institute
Co-authored papers
1
Ludwig Dubois
Maastricht University
Co-authored papers
1
Nikhil Thapar
Queensland Children's Hospital
Co-authored papers
1
Meike de Wit
The Netherlands Cancer Institute
Co-authored papers
1
1 - 25